参考文献/资料:
[1]Ruiz M A, Clares B, Morales M E, et al. Evaluation of the anti-wrinkle efficacy of cosmetic formulations with an anti-aging peptide (Argireline®)[J]. Ars Pharm, 2010, 50(4): 168-176.
[2]Lungu C, Considine E, Zahir S, et al. Pilot study of topical acetyl hexapeptide‐8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy[J]. European journal of neurology, 2013, 20(3): 515-518.
[3]J.D. Carruthers and J.A. Carruthers, Treatment of glabellar frown lines with C. botulinum-A exotoxin, J. Dermatol. Surg. Oncol., 18, 17-21 (1992).
[4]M. Fernández-Lorente, I. Aldanondo and P. Jaén, Efectos secundarios de la toxina botulínica, Piel, 20(9), 474-480 (2005).
[5]G. C. Singh, M. C. Hankins, A. Dulku and M. B. Kelly, Psychosocial aspects of botox in aesthetic surgery, Aesthetic Plast. Surg., 30, 71-76 (2006).
[6]M.A. Ruiz, B. Clares, M.E. Morales, S. Cazalla and V. Gallardo, Preparatyon and stability of cosmetic formulations with an anti-aging peptide, J Cosmet. Sci., 58, 157-171 (2007).
[7]M. A. Ruiz , M. Pleguezuelos, M. Muñoz and V. Gallardo, Moisturizing capacity of aloe vera gel in skin creams made with silicone-based and olive oil-based latex preparations, J. of appl. Cosmet., 22, 25-33 (2004).
[8]H. Stone, andJ.L Sidel, Sensory evaluation for skin care products, Cosmet. & Toilet., 101, 45- 50 (1986).
[9]A. Thibodeau, Inhibidores de Metaloproteinasas, NCP, 281, 5-10 (2005).
[10]N.M. Craven, R.E.V. Watson, C.J.P. Jones, C.A. Schuttleworth, C.M. Kielly and C.E.M. Griffiths, Clinical features of photodamaged human skin are associated with a reduction in collagen VII, Br. J. Dermatol., 137, 344-350 (1997).
[11]F.A. Fenske and C.W. Lober, Continuing and functional changes of normal aging skin, J Arner. Acad. Dermatol., 15(4), 571-585 (1986).
[12]M.T.Alcalde, Productos cosméticos con efecto botox, OFFARM Farmacia y Sociedad, 23, 92- 99 (2004).
[13]Blanes-Mira, C., Clemente, J., Jodas, G., Gil, A., Fernandez-Ballester, G., Ponsati, B. et al.A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int. J. Cosmet. Sci. 24, 303–310 (2002).
[14]Foran, P.G., Mohammed, N., Lisk, G.O., Nagwaney, S., Lawrence, G.W., Johnson, E. et al.Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A: Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 278, 1363–1371 (2003).
[15]Gutierrez, L.M., Viniegra, S., Rueda, J., Ferrer-Montiel, A.V., Canaves, J.M. and Montal, M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Biol. Chem. 272, 2634–2639 (1997).
[16]Gutierrez, L.M., Canaves, J.M., Ferrer-Montiel, A.V., Reig, J.A., Montal, M. and Viniegra, S. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells. FEBS Lett. 372, 39–43 (1995).
[17]International Journal of Cosmetic Science,2002,24,303-310